Cargando…

Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms

α(2)-Macroglobulin (α(2)M) is an extracellular chaperone that inhibits amorphous and fibrillar protein aggregation. The reaction of α(2)M with proteases results in an ‘activated’ conformation, where the proteases become covalently-linked within the interior of a cage-like structure formed by α(2)M....

Descripción completa

Detalles Bibliográficos
Autores principales: Wyatt, Amy R., Constantinescu, Patrick, Ecroyd, Heath, Dobson, Christopher M., Wilson, Mark R., Kumita, Janet R., Yerbury, Justin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science B.V 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581772/
https://www.ncbi.nlm.nih.gov/pubmed/23353684
http://dx.doi.org/10.1016/j.febslet.2013.01.020
_version_ 1782260512829997056
author Wyatt, Amy R.
Constantinescu, Patrick
Ecroyd, Heath
Dobson, Christopher M.
Wilson, Mark R.
Kumita, Janet R.
Yerbury, Justin J.
author_facet Wyatt, Amy R.
Constantinescu, Patrick
Ecroyd, Heath
Dobson, Christopher M.
Wilson, Mark R.
Kumita, Janet R.
Yerbury, Justin J.
author_sort Wyatt, Amy R.
collection PubMed
description α(2)-Macroglobulin (α(2)M) is an extracellular chaperone that inhibits amorphous and fibrillar protein aggregation. The reaction of α(2)M with proteases results in an ‘activated’ conformation, where the proteases become covalently-linked within the interior of a cage-like structure formed by α(2)M. This study investigates, the effect of activation on the ability of α(2)M to inhibit amyloid formation by Aβ(1–42) and I59T human lysozyme and shows that protease-activated α(2)M can act via two distinct mechanisms: (i) by trapping proteases that remain able to degrade polypeptide chains and (ii) by a chaperone action that prevents misfolded clients from continuing along the amyloid forming pathway. STRUCTURED SUMMARY OF PROTEIN INTERACTIONS: Aβ(1–42) and Aβ(1–42) bind by fluorescence technology (View interaction)I59T lysozyme and I59T lysozyme bind by light scattering (View interaction)I59T lysozyme and I59T lysozyme bind by fluorescence technology (View interaction)Alpha-lactalbumin and Alpha-lactalbumin bind by fluorescence technology (View interaction)I59T lysozyme and I59T lysozyme bind by electron microscopy (View interaction)Aβ(1–42) and Aβ(1–42) bind by electron microscopy (View interaction)
format Online
Article
Text
id pubmed-3581772
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Elsevier Science B.V
record_format MEDLINE/PubMed
spelling pubmed-35817722013-03-01 Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms Wyatt, Amy R. Constantinescu, Patrick Ecroyd, Heath Dobson, Christopher M. Wilson, Mark R. Kumita, Janet R. Yerbury, Justin J. FEBS Lett Article α(2)-Macroglobulin (α(2)M) is an extracellular chaperone that inhibits amorphous and fibrillar protein aggregation. The reaction of α(2)M with proteases results in an ‘activated’ conformation, where the proteases become covalently-linked within the interior of a cage-like structure formed by α(2)M. This study investigates, the effect of activation on the ability of α(2)M to inhibit amyloid formation by Aβ(1–42) and I59T human lysozyme and shows that protease-activated α(2)M can act via two distinct mechanisms: (i) by trapping proteases that remain able to degrade polypeptide chains and (ii) by a chaperone action that prevents misfolded clients from continuing along the amyloid forming pathway. STRUCTURED SUMMARY OF PROTEIN INTERACTIONS: Aβ(1–42) and Aβ(1–42) bind by fluorescence technology (View interaction)I59T lysozyme and I59T lysozyme bind by light scattering (View interaction)I59T lysozyme and I59T lysozyme bind by fluorescence technology (View interaction)Alpha-lactalbumin and Alpha-lactalbumin bind by fluorescence technology (View interaction)I59T lysozyme and I59T lysozyme bind by electron microscopy (View interaction)Aβ(1–42) and Aβ(1–42) bind by electron microscopy (View interaction) Elsevier Science B.V 2013-03-01 /pmc/articles/PMC3581772/ /pubmed/23353684 http://dx.doi.org/10.1016/j.febslet.2013.01.020 Text en © 2013 Elsevier B.V. https://creativecommons.org/licenses/by/3.0/ Open Access under CC BY 3.0 (https://creativecommons.org/licenses/by/3.0/) license
spellingShingle Article
Wyatt, Amy R.
Constantinescu, Patrick
Ecroyd, Heath
Dobson, Christopher M.
Wilson, Mark R.
Kumita, Janet R.
Yerbury, Justin J.
Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms
title Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms
title_full Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms
title_fullStr Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms
title_full_unstemmed Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms
title_short Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms
title_sort protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581772/
https://www.ncbi.nlm.nih.gov/pubmed/23353684
http://dx.doi.org/10.1016/j.febslet.2013.01.020
work_keys_str_mv AT wyattamyr proteaseactivatedalpha2macroglobulincaninhibitamyloidformationviatwodistinctmechanisms
AT constantinescupatrick proteaseactivatedalpha2macroglobulincaninhibitamyloidformationviatwodistinctmechanisms
AT ecroydheath proteaseactivatedalpha2macroglobulincaninhibitamyloidformationviatwodistinctmechanisms
AT dobsonchristopherm proteaseactivatedalpha2macroglobulincaninhibitamyloidformationviatwodistinctmechanisms
AT wilsonmarkr proteaseactivatedalpha2macroglobulincaninhibitamyloidformationviatwodistinctmechanisms
AT kumitajanetr proteaseactivatedalpha2macroglobulincaninhibitamyloidformationviatwodistinctmechanisms
AT yerburyjustinj proteaseactivatedalpha2macroglobulincaninhibitamyloidformationviatwodistinctmechanisms